Navigation Links
A Jekyll and Hyde of cytokines: IL-25 both promotes and limits inflammatory diseases

The same signal responsible for promoting the type of immune responses that cause asthma and allergy can also limit the type of inflammation associated with debilitating diseases like inflammatory bowel disease, arthritis and multiple sclerosis, according to researchers from the University of Pennsylvania School of Veterinary Medicine. The researchers discovered how IL-25, a signaling protein known as a cytokine, both prevents destructive inflammation and promotes immune responses associated with asthma and allergic responses.

The findings, which appear the April issue of the Journal of Experimental Medicine, suggest that manipulating IL-25 could provide a method to treat a wide variety of chronic inflammatory diseases.

"It appears that IL-25 has a Jekyll and Hyde personality: it can be helpful or hurtful depending on how it interacts with T helper cells, a subset of immune cells that influences inflammatory responses," said David Artis, an assistant professor in Penn's Department of Pathobiology and senior author of the study. "These studies show that IL-25 promotes type 2 T helper cells that drive the type of response required for eradicating worm infections and causing asthma. Importantly, IL-25 can simultaneously limit destructive inflammation caused by inflammatory T helper cells commonly found in diseases like inflammatory bowel disease, arthritis and MS."

IL-25 can be considered a "good" cytokine by limiting chronic inflammatory responses. At the same time, the ability of IL-25 to promote type 2 responses that drive asthma could be considered the "evil" side of the cytokine.

By examining mice infected with Trichuris, a species of intestinal parasites known as whipworms, the researchers were able to define IL-25's role in promoting type 2 inflammation to fight infection. In mice that lack the ability to produce IL-25, researchers saw a dramatic reduction in the ability to mount a type 2 response that eradicates the parasit
'"/>

Source:University of Pennsylvania


Page: 1 2

Related biology news :

1. Have a taste for fat? Yes! A sensor in the mouth promotes preference for fatty foods
2. Texas scientists discover how a hepatitis C protein promotes liver cancer
3. Meth promotes spread of virus in HIV-infected users
4. Serotonin, acting in a specific brain region, promotes sleep in fruit flies
5. Salk scientists hammer out a pathway that promotes muscle cell survival in mice
6. Scientists narrow the time limits for the human and chimpanzee split
7. Researchers report new pro-inflammatory role for anti-inflammatory enzyme
8. Scientists at Galileo Pharmaceuticals confirm inflammatory response linked to glucose levels
9. Protein finding could lead to treatment for inflammatory diseases
10. Anti-inflammatory drugs potentially deadly side effect found to be rare
11. Selectively blocking inflammatory signals may protect mice from MS

Post Your Comments:
(Date:11/30/2009)...r thought the stress of seeing your extended famil...: a new research report in the December 2009 print...p://www.jleukbio.org ) shows that you might be rig...udy might lead to entirely new treatments that hel...and eczema under control. That,s because researche...
(Date:11/30/2009)... a colorless and odorless radioactive gas that is ...m is a product of uranium decay and is found in tr...and groundwater as well as building materials, pla...ntration is expressed as the amount of radiation t...ts in a liter of air; thus the units are picocurie...
(Date:11/26/2009)... have at last worked out a way of using recordings...d populations. This is the first time sound record...into accurate estimates of bird species, populatio...tish Ecological Society,s Journal of Applied Ecol...d to a major advance in our ability to monitor wha...
Breaking Biology News(10 mins):Seeing family for the holidays? Scientists discover how the stress might kill you 2Health Physics Society recommends considering action for indoor radon below current guidelines 2Ecologists sound out new solution for monitoring cryptic species 2GfK Asia Reports 3A Malaysian Contact Lens Market Sees Strong Recovery in Second Half of 2009 61405 1GfK Asia Reports 3A Malaysian Contact Lens Market Sees Strong Recovery in Second Half of 2009 61405 2GfK Asia Reports 3A Malaysian Contact Lens Market Sees Strong Recovery in Second Half of 2009 61405 3Frost 26amp 3B Sullivan Reveals Strategies on Turning Challenges into Opportunities in the European Biomarkers Market 14842 1Frost 26amp 3B Sullivan Reveals Strategies on Turning Challenges into Opportunities in the European Biomarkers Market 14842 2New View Of Reality 28In Printed Book Form 29 That Combines Einstein And Quantum Mechanics And Fills The World With Miracles 61401 1New View Of Reality 28In Printed Book Form 29 That Combines Einstein And Quantum Mechanics And Fills The World With Miracles 61401 2New View Of Reality 28In Printed Book Form 29 That Combines Einstein And Quantum Mechanics And Fills The World With Miracles 61401 3
...ational Academy of Sciences, Sackler Colloquium se...ks. These networks represent the genomic program ... and cell types. The meeting will focus on four a...y embryonic development; gene networks later devel...x multigenic systems; and understanding the genera...
...s release is also available in French . Resear...Gill University have identified the neurological b...g post-concussion symptoms. The study, published i...ry, has important clinical implications for the tr...l concussion. , Depression is one of a number of...
...T CREEK, CA--A preliminary assembly and annotation... available by the U.S. Department of Energy Joint ...fic community to enable bioenergy research. , The...ctor, during his keynote remarks Jan. 15 at the Pl...CA. The preliminary data can be accessed at http:...
Other Biology News:MNI researchers locate neurological basis of depression following sports concussion 2DOE JGI releases soybean genome assembly to enable worldwide bioenergy research efforts 2DOE JGI releases soybean genome assembly to enable worldwide bioenergy research efforts 3
(Date:12/1/2009)...t Software agrees to migrate their Microsoft Dynam...ts) to Synergy Business Solutions to maintain qual...A (PRWEB) December 1, 2009 -- Synergy Business Sol...ft Dynamics SL practice of Congruent Software, a B... was necessary due to a change in Congruent Softwa...
(Date:12/1/2009)...c. 1 Aethlon Medical, In... it will present at the LD MICRO Conference on Thu...Luxe Hotel in Los Angeles. Aethlon Medical,s Chair...ate overview and will provide an update on the com... Hemopurifier®, a first-in-class artificial a...
(Date:12/1/2009)...H VANCOUVER, British Columbia, Dec. 1 /PRNewswire-... subsidiary of The Dow Chemical Company (NYSE: D...ed the signing of a research and commercial licens...oSciences with access to Agrisoma,s proprietary En...ve basis in major food crops, and on a non-exclusi...
(Date:12/1/2009)... Medizone International,...hat in tests involving its proprietary AsepticSure...ontamination barriers, this time with two very dif...ile and Bacillis subtilis. These results clearly e...oricidal technology. "The implications of a 6.7 lo...
Breaking Biology Technology:Synergy Business Solutions Acquires the Microsoft Dynamics SL Practice of Congruent Software, Inc. 2Synergy Business Solutions Acquires the Microsoft Dynamics SL Practice of Congruent Software, Inc. 3Aethlon Medical to Present at LD MICRO Conference on December 3, 2009 2Dow AgroSciences, Agrisoma Biosciences Announce Research and Commercial License Option Agreement for Agricultural Crops 2Dow AgroSciences, Agrisoma Biosciences Announce Research and Commercial License Option Agreement for Agricultural Crops 3Medizone International Takes Aim at the Bioterrorism Countermeasures Arena 2
... DC A new analysis by the Project on Emerging Nan...s are investing nearly twice as much as the U.S. i...tial risks of nanotechnology. The analysis also hi...al governments nanotechnology risk-research invest...nt of nanotechnology risk-relevant projects identi...
... April 21 Boston Scientific,Corporation (NYSE: B...st,quarter ended March 31, 2008, as well as guidan...the second quarter of 2008., First quarter highl...nd adjusted EPS of $0.24 -- Improved earnings thr...ntained leading position in the worldwide drug-elu...
...erence Call Today at 5:00 p.m., CAMBRIDGE, Mass.,...nounced today that the FDA has informed the,compan...fa) produced at the,160L bioreactor scale and Myoz...ed as two different products because of difference... Currently, Genzyme has U.S.,approval to sell Myoz...
Other Biology Technology:Europe spends nearly twice as much as US on nanotech risk research 2Boston Scientific Announces Results for First Quarter Ended March 31, 2008 2Boston Scientific Announces Results for First Quarter Ended March 31, 2008 3Boston Scientific Announces Results for First Quarter Ended March 31, 2008 4Boston Scientific Announces Results for First Quarter Ended March 31, 2008 5Boston Scientific Announces Results for First Quarter Ended March 31, 2008 6Boston Scientific Announces Results for First Quarter Ended March 31, 2008 7Boston Scientific Announces Results for First Quarter Ended March 31, 2008 8Boston Scientific Announces Results for First Quarter Ended March 31, 2008 9Boston Scientific Announces Results for First Quarter Ended March 31, 2008 10Boston Scientific Announces Results for First Quarter Ended March 31, 2008 11Boston Scientific Announces Results for First Quarter Ended March 31, 2008 12Boston Scientific Announces Results for First Quarter Ended March 31, 2008 13Boston Scientific Announces Results for First Quarter Ended March 31, 2008 14Boston Scientific Announces Results for First Quarter Ended March 31, 2008 15Boston Scientific Announces Results for First Quarter Ended March 31, 2008 16Boston Scientific Announces Results for First Quarter Ended March 31, 2008 17Boston Scientific Announces Results for First Quarter Ended March 31, 2008 18Genzyme Provides Update on Myozyme(R) Manufacturing 2Genzyme Provides Update on Myozyme(R) Manufacturing 3Genzyme Provides Update on Myozyme(R) Manufacturing 4Genzyme Provides Update on Myozyme(R) Manufacturing 5
Chaps Cell Extract Buffer (10X) from Cell Signaling Technology
Mouse Anti-TGE Virus peplomer Monoclonal Antibody, Unconjugated, Clone 1Q17 from Abcam
Mouse Anti-Human B3GALT2 Polyclonal Antibody, Unconjugated from ABR-Affinity BioReagents
Rabbit Anti-Lck, phospho (Tyr192) Polyclonal Antibody, Unconjugated from Abcam
Biology Products: